about
β-Lapachone ameliorates lipotoxic cardiomyopathy in acyl CoA synthase transgenic miceCardiomyocyte-specific perilipin 5 overexpression leads to myocardial steatosis and modest cardiac dysfunctionHigh-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation.Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunctionMale-Specific Cardiac Dysfunction in CTP:Phosphoethanolamine Cytidylyltransferase (Pcyt2)-Deficient MiceProtection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation.Fatty acids identified in the Burmese python promote beneficial cardiac growth.Macrophages modulate cardiac function in lipotoxic cardiomyopathy.Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation.Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice.The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats.Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity.APPL1 transgenic mice are protected from high-fat diet-induced cardiac dysfunction.
P2860
Q28540678-F524DC75-D257-4B17-97D0-087A4A14F8B3Q28589187-C88F22BA-79BE-4881-885A-1E8B359A0F41Q33584533-42CB13C2-B33E-490B-A38F-0A282422B259Q34718192-568222F8-E03B-4724-9F46-C17ED714A2D5Q35739201-7B39140B-85C9-4C39-8ABA-4C05E48238BCQ35914024-0C5713FC-445D-4624-B1FD-DA51549F3DBBQ36014621-065A8D94-4095-4EE5-BB3D-8AA04F3A758DQ36060351-54DBE519-0353-49C6-83B4-97C75E2391A8Q36494659-CC15FD51-7CA5-455E-A893-B2397D905A1BQ37032295-385AF762-942E-4B18-B1F9-9F06553A73EBQ38324690-AAE63D05-236B-4197-ABDE-9F59726711ADQ39581594-B27AD8C9-7404-466F-9E26-A330F9FC50F3Q43821283-16E2EE4E-111D-41F0-9FCE-75FA3496BBBBQ47845157-25C4DD0E-96C4-4F77-A496-234A879AE7F6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Creating and curing fatty hearts.
@en
Creating and curing fatty hearts.
@nl
type
label
Creating and curing fatty hearts.
@en
Creating and curing fatty hearts.
@nl
prefLabel
Creating and curing fatty hearts.
@en
Creating and curing fatty hearts.
@nl
P2093
P2860
P1476
Creating and curing fatty hearts.
@en
P2093
Ira J Goldberg
Konstaninos Drosatos
Raffay S Khan
P2860
P304
P356
10.1097/MCO.0B013E3283357272
P577
2010-03-01T00:00:00Z